Indian Regorafenib Exporters: Complete Supplier Ranking with Market Share — 73 Manufacturers (2026) — TransData Nexus

Q: Who is the largest regorafenib buyer importing from India?

STR INTERNATIONAL TRADING CO., LTD (THAILAND) is the largest regorafenib importer from India with a 6.3% market share and import value of $63.2K.

Q: How many regorafenib buyers import from India?

There are 73 active regorafenib buyers importing from India, with a combined import market of $1.0M across 154 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top regorafenib buyers from India?

The top 5 regorafenib buyers — STR INTERNATIONAL TRADING CO., LTD, STR INTERNATIONAL TRADING CO. LIMITED, STR INTERNATIONAL TRADING CO., LIMITED, CLIENT CODE PH001,, BZ COMPNAT LIMITED — together control 10.0% of total regorafenib import value from India.

Suresh Sormare

Regorafenib

India Pharmaceutical Trade Intelligence

$1.0M60 Suppliers37 CountriesHS 30049099

ExportsIndia → FRANCE73.8%India → THAILAND9.3%

ImportsUNITED STATES → India$246.8K GERMANY → India$125.9K

#1 Supplier: KARDI TRADING

Market Analysis: Top Importing Countries & Their Importers

1France

France emerges as the first largest importing country, achieving a total trade value of $743.0K through 0 shipments. This represents a market share of 73.8% of the total market activity, demonstrating their significant presence in the industry.

Key Insight: France demonstrates strong market positioning with an average shipment value of $743.0K, indicating premium pricing strategy compared to the market average of $6.5K.

France is a key market for Regorafenib imports, representing 73.8% of total trade value.

Primary Market

Secondary Market

2Thailand

Thailand emerges as the second largest importing country, achieving a total trade value of $93.3K through 9 shipments. This represents a market share of 9.3% of the total market activity, demonstrating their significant presence in the industry.

Top Importers: Thailand has a diverse importer base, with their top importers including:

• STR INTERNATIONAL TRADING CO., LTD - $63.2K (67.7% of country's total business)

• - $12.2K (13.0% of country's total business)

Buyer Segment Analysis

TransData Nexus Regorafenib buyer market intelligence

1Buyer Segment Analysis

The importers of Regorafenib from India can be categorized into several segments:

1. Distributors: Entities like STR International Trading Co., Ltd and its variants in Thailand, as well as BZ Compnat Limited, likely function as distributors. They procure Regorafenib in bulk to supply to local healthcare providers, pharmacies, or other intermediaries. Their purchasing patterns typically involve large, periodic orders aligned with market demand forecasts.

2. Re-exporters: Companies such as ZMC Express Cargo FZCO in Iraq and Vanterpool Enterprises Ltd in the British Virgin Islands may act as re-exporters. They import pharmaceuticals to redistribute them to other markets, often leveraging favorable trade agreements or logistical advantages. Their buying behavior is characterized by variable order sizes, influenced by the demands of their target export destinations.

3. Government Procurement Agencies: Entities like Client Code PH001 in the Philippines might represent government procurement bodies or agencies involved in national tenders. These organizations typically engage in bulk purchasing through formal tender processes to supply public healthcare facilities. Their procurement cycles are often annual or bi-annual, depending on budget allocations and healthcare program requirements.

4. Hospital Groups and Retail Chains: While specific hospital groups or retail chains are not explicitly identified among the top buyers, it's plausible that some importers serve these segments. These buyers usually place consistent, moderate-sized orders to maintain adequate stock levels for patient care, with purchasing patterns reflecting treatment protocols and patient inflow.

The repeat buyer rate of 38.4% indicates a moderate level of recurring demand, suggesting that while some buyers maintain ongoing procurement relationships, a significant portion of the market consists of one-time or sporadic purchasers.

Country-Specific Import Regulations

TransData Nexus Regorafenib buyer market intelligence

1Country-Specific Import Regulations

Understanding the import regulations for Regorafenib in the top importing countries is crucial for market entry and compliance.

1. France:

Regulatory Authority: Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM).

Import Registration Process: Importers must obtain a Marketing Authorization (MA) from ANSM, which involves submitting a comprehensive dossier including clinical data, manufacturing details, and labeling information.

Estimated Timeline: The MA process typically takes 210 days, subject to the completeness of the application and any additional information requests.

Import Tariff/Duty: Pharmaceutical products under HS Code 30049099 are generally subject to a 0% import duty within the European Union, including France.

2. Thailand:

Regulatory Authority: Thai Food and Drug Administration (Thai FDA).

Demand Drivers & Market Opportunity

TransData Nexus Regorafenib buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Regorafenib in importing countries is influenced by several factors:

1. Disease Prevalence: Regorafenib is primarily used in the treatment of metastatic colorectal cancer, gastrointestinal stromal tumors, and hepatocellular carcinoma. The prevalence of these cancers in importing countries directly impacts demand. For instance, according to the World Health Organization (WHO), colorectal cancer is among the top five cancers in France, contributing to significant demand for effective treatments like Regorafenib.

2. Government Healthcare Programs: Many countries have national healthcare programs that subsidize or fully cover the cost of essential medicines. In Thailand, the Universal Coverage Scheme provides access to necessary medications for its citizens, potentially increasing the demand for Regorafenib.

3. Universal Health Coverage Expansion: Countries expanding their universal health coverage are likely to see increased demand for essential medicines. Kenya's efforts to achieve universal health coverage by 2022 have included initiatives to improve access to cancer treatments, which may drive demand for Regorafenib.

4. WHO Essential Medicines List Procurement: Inclusion of a drug in the WHO Essential Medicines List (EML) can influence its procurement by countries aiming to align with WHO recommendations. While Regorafenib is not currently listed in the WHO EML, its recognition as a critical cancer treatment may prompt countries to include it in their national EMLs, thereby increasing demand.

5. Tender-Based Purchasing: Government and large healthcare institutions often procure medicines through tender processes to ensure cost-effectiveness and supply security. The presence of 73 buyers across 37 countries, as per our data, indicates a competitive market where tender-based purchasing is a common practice, influencing the demand dynamics for Regorafenib.

Common Questions — Regorafenib Buyers & Importers

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

QWho is the largest regorafenib buyer importing from India?

Based on import volume and value, STR INTERNATIONAL TRADING CO., LTD (THAILAND) leads with $63.2K in imports and a 6.3% market share — the highest of any single regorafenib importer. STR INTERNATIONAL TRADING CO. LIMITED (THAILAND) and STR INTERNATIONAL TRADING CO., LIMITED (THAILAND) are the next largest buyers.

QHow many companies buy regorafenib from India?

There are 73 active regorafenib buyers importing from India, with a combined market of $1.0M across 154 shipments to 37 countries. The top 5 buyers hold 10.0% of total import value, while the remaining 68 buyers handle the other 90.0%.

QWhich countries import the most regorafenib from India?

The top importing countries for regorafenib from India are France (73.8%), Thailand (9.3%), Kenya (3.6%), Hong Kong (2.8%), Iraq (1.8%). These markets represent the largest demand centres for Indian pharmaceutical exports of regorafenib, with buyers ranging from government procurement agencies to private pharmaceutical distributors.

QWhat is the average import order value for regorafenib from India?

The average import transaction value for regorafenib from India is , with an average unit price of . Order sizes vary significantly based on buyer type — government tenders tend to be larger while private distributors place more frequent smaller orders.

Buyer Segment Analysis

TransData Nexus Regorafenib buyer market intelligence

1Buyer Segment Analysis

The importers of Regorafenib from India can be categorized into several segments:

Country-Specific Import Regulations

TransData Nexus Regorafenib buyer market intelligence

1Country-Specific Import Regulations

Understanding the import regulations for Regorafenib in the top importing countries is crucial for market entry and compliance.

1. France:

Regulatory Authority: Agence Nationale de Sécurité du Médicament et des Produits de Santé (ANSM).

Estimated Timeline: The MA process typically takes 210 days, subject to the completeness of the application and any additional information requests.

Import Tariff/Duty: Pharmaceutical products under HS Code 30049099 are generally subject to a 0% import duty within the European Union, including France.

2. Thailand:

Regulatory Authority: Thai Food and Drug Administration (Thai FDA).

Demand Drivers & Market Opportunity

TransData Nexus Regorafenib buyer market intelligence

1Demand Drivers & Market Opportunity

The demand for Regorafenib in importing countries is influenced by several factors:

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Regorafenib

Regorafenib

Who Buys Regorafenib from India — 73 Importers Behind a $1.0M Market

Top Regorafenib Importers — Ranked by Import Value

Top Regorafenib Buyers & Importers

Related Analysis

Need Details?

Market Analysis: Top Importing Countries & Importers

Which companies are buying Regorafenib — and from which countries?

Regorafenib — Buyer Countries to Key Importers

Market Analysis: Top Importing Countries & Their Importers

1France

2Thailand

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Common Questions — Regorafenib Buyers & Importers

QWho is the largest regorafenib buyer importing from India?

QHow many companies buy regorafenib from India?

QWhich countries import the most regorafenib from India?

QWhat is the average import order value for regorafenib from India?

Buyer Segment Analysis

1Buyer Segment Analysis

Country-Specific Import Regulations

1Country-Specific Import Regulations

Demand Drivers & Market Opportunity

1Demand Drivers & Market Opportunity

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

3Kenya

4Hong Kong

5Iraq

Analysis Methodology